gamma delta T-cell lymphoma is a rare T-cell lymphoproliferative disorder t
hat has been reported in both immunocompetent and immunocompromised persons
. This report describes a forty eight year old patient who developed gamma
delta T-cell lymphoma four years after undergoing living-related kidney tra
nsplantation. The lymphoma expressed CD2, CD3, CD7, CD8 and CD56, and the g
amma delta T-cell receptor and did not express CD5, CD4 and the alpha beta
T-cell receptor. In addition, HHV-6 was cultured from the patient's bone ma
rrow, marking the first time that this virus has been associated with gamma
delta T-cell lymphoma. Since all patients with gamma delta T-cell lymphoma
described to date have responded poorly to standard combination chemothera
pies, the patient was treated with the purine analogue 2-chlorodeoxyadenosi
ne. While he responded transiently to treatment, long term remission was no
t achieved indicating that additional therapeutic approches still need to b
e developed, for the management of this disorder.